Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Madrigal Pharmaceuticals (MDGL)

TipRanksDec 18 13:50 · Ratings

Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.

Dow JonesDec 17 19:27 · Ratings

Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BusinesswireDec 17 05:01

Cantor Fitzgerald Reiterates Overweight on Arcturus Therapeuticsto Overweight

BenzingaDec 16 21:16

Arcturus Therapeutics Analyst Ratings

BenzingaDec 16 21:14 · Ratings

This Arcturus Therapeutics Holdings Insider Reduced Their Stake By 18%

Simply Wall StDec 14 21:08